tert-Butyl 4-cyano-4-(3-methoxyphenyl)piperidine-1-carboxylate

Catalog No.: 
ACUBZR319
CAS No.: 
553631-35-9
Molecular Formula: 
C18H24N2O3
Molecular Weight: 
316.40
tert-Butyl 4-cyano-4-(3-methoxyphenyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$147.00InquiryInquiry
250mg95%$269.00InquiryInquiry
1g95%$1054.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-cyano-4-(3-methoxyphenyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-cyano-4-(3-methoxyphenyl)piperidine-1-carboxylate
MDL No.MFCD11849790
Molecular FormulaC18H24N2O3
Molecular Weight316.40
SMILESCOC1=CC=CC(=C1)C1(CCN(CC1)C(=O)OC(C)(C)C)C#N
InChI KeyCAWFUTWCSVOOPD-UHFFFAOYSA-N
Synonym1-BOC-4-CYANO-4-(3-METHOXYPHENYL)-PIPERIDINE;1-Piperidinecarboxylic acid, 4-cyano-4-(3-methoxyphenyl)-, 1,1-dimethylethyl ester;Tert-butyl 4-cyano-4-(3-methoxyphenyl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-cyano-4-(3-methoxyphenyl)-, 1,1-dimethylethyl ...
CAS No.553631-35-9

Synthetic Route by SureRoute

1. ACUBZR319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBZR319 route product structure diagram
    ACUBZR319553631-35-9
Inquiry

2. ACUBZR319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUBZR319 route product structure diagram
    ACUBZR319553631-35-9
Inquiry

3. ACUBZR319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBZR319 route product structure diagram
    ACUBZR319553631-35-9
Inquiry

Comments (0)